Actinogen Medical Limited (ASX:ACW) has requested a trading halt pending an announcement regarding a capital raising and share purchase plan. The halt is expected to remain in place until the announcement is released or no later than 10.00 am AEST on Wednesday, 18 September 2024.
The Company, Actinogen Medical Limited, has requested the trading halt in accordance with ASX Listing Rule 17.1. The halt is sought in anticipation of an upcoming announcement related to a capital raising and share purchase plan. The Company Secretary, Peter Webse, has expressed that the Company is not aware of any reason why the trading halt should not be granted by ASX Limited.
Actinogen Medical Limited (ASX:ACW) has made a formal request to ASX for a trading halt as it prepares to make an announcement regarding a capital raising and share purchase plan. The halt is expected to be in place until the announcement is released or no later than 10.00 am AEST on Wednesday, 18 September 2024. The Company has conveyed its lack of awareness of any reason for the trading halt not to be granted. Investors and stakeholders are advised to await the forthcoming announcement for further details regarding the capital raising and share purchase plan.